-- India's Ranbaxy slumps after U.S. FDA bans more products
-- By Abhishek Vishnoi
-- Thu Jan 23, 2014 10:41PM EST
-- None



MUMBAI, Jan 24 (Reuters) - Shares in India's Ranbaxy Laboratories Ltd <RANB.NS>, majority owned by Japan's Daiichi Sankyo Co Ltd <4568.T>, slumped 10 percent in pre-open trade after the U.S. Food and Drug Administration banned more products from the Indian drugmaker.

